New York, New York (PRWEB) November 23, 2013
The New Jersey Multicounty Litigation established in Bergen County Superior Court for all Stryker hip lawsuit (http://www.strykerhiprecallclaims.com/) claims involving Rejuvenate and ABG II Modular-Neck Hip Stems held its most recent Case Management Conference on November 18, 2013, Bernstein Liebhard LLP reports. According to an Order issued that same day, the Court will embark on Phase I of early mediation next month, with mediation sessions scheduled for a number of Stryker Hip recall claims beginning on December 4, 2013. According to the Order, the parties have also been directed to meet and confer on the selection of cases for Phase II of early mediation no later than December 16, 2013. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“We are representing a number of plaintiffs who have Stryker hip lawsuits pending in this litigation. We are pleased to see these cases moving forward, and look ahead to even greater progress in the year to come,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal evaluations to individuals who may have been injured by the devices involved in the Stryker hip recall for Rejuvenate and ABG II hip stems.
Stryker Hip Recall
Court documents indicate that since the Stryker hip recall for Rejuvenate and ABG II hip stems was announced in July 2012, more than 900 product liability lawsuits alleging injury due to the components have been filed in courts around the country. In addition to 553 Stryker hip lawsuits pending in New Jersey, another 395 have also been filed in a federal multidistrict litigation underway in U.S. District Court, District of Minnesota. ( In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441) All of the claims pending in these proceedings involve similar allegations regarding the recalled components’ association with serious complications, including metallosis, adverse local tissue reactions, necrosis, and failure of the hip, that are the result of fretting and corrosion at the modular-neck junction.
Stryker announced a worldwide recall of Rejuvenate and ABG II hip stems in July 2012. According to the company, fretting and corrosion of the hip stems puts patients at risk for adverse local tissue reactions, pain, swelling, and other complications that may necessitate revision of the hip. The company has advised all individuals affected by the Stryker hip recall to undergo medical screening, including blood tests for metal ion levels and cross-sectional imaging, even if they are not experiencing any symptoms that might indicate a problem.*
Alleged victims of complications related to Rejuvenate and ABG II hip stems may be entitled to financial compensation from Stryker. To learn more about the potential problems associated with Rejuvenate and ABG II Modular-Neck Hip Stems, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP